TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16562684

Group type: EXPERIMENTAL
Intervention: Fentanyl 30 microg/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fentanyl 60 microg/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fentanyl 100 microg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study: 12950572

Group type: EXPERIMENTAL
Intervention: Conventional root-canal hand instrumentation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Noninstrumentation technique (NIT)
Number of subjects: 40
Study: 11027424

Group type: EXPERIMENTAL
Intervention: CarboMIP regimen (cisplatin 60 mg m(‐2) and carboplatin 200 mg m(‐2) with mitomycin 6 mg m(‐2) and ifosfamide 3 g m(‐2))
Number of subjects: 305

Group type: COMPARATOR
Intervention: MIP regimen (cisplatin 50 mg m(‐2) with mitomycin 6 mg m(‐2) and ifosfamide 3 g m(‐2))
Number of subjects: 305
Study: 9099320

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 8017600

Group type: EXPERIMENTAL
Intervention: Continuous regional analgesia (interpleural and epidural infusions)
Number of subjects: 2630

Group type: COMPARATOR
Intervention: Intravenous opioid administration
Number of subjects: 2630
Study: 3065741

Group type: EXPERIMENTAL
Intervention: CHOP regimen
Number of subjects: 973

Group type: COMPARATOR
Intervention: COP regimen
Number of subjects: 973

Group type: COMPARATOR
Intervention: Chlorambucil (daily indefinite course)
Number of subjects: 973

Group type: COMPARATOR
Intervention: Intermittent chlorambucil-prednisone
Number of subjects: 973
Study: 29582088

Group type: EXPERIMENTAL
Intervention: CHOICE intervention (n=150)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Usual care (n=154)
Number of subjects: 304
Study: 26198928

Group type: EXPERIMENTAL
Intervention: 50,000 IU vitamin D3 every five days for 12 weeks
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 23289373

Group type: EXPERIMENTAL
Intervention: Gain-framed message with additive counterfactual thinking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loss-framed message with subtractive counterfactual thinking
Number of subjects: 0
Study: 21251831

Group type: COMPARATOR
Intervention: No additional load
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 10 kg load suspended from the waist
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 30 kg load suspended from the waist
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 10 kg load across the rear of the shoulders
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 30 kg load across the rear of the shoulders
Number of subjects: 13
Study: 18812129

Group type: EXPERIMENTAL
Intervention: Vitrectomy combined with cataract surgery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Significant cataract only (control group)
Number of subjects: 80
Study: 16131531

Group type: EXPERIMENTAL
Intervention: Morphine (100 microg/kg + 10 microg/kg/h)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Additional morphine
Number of subjects: 144
Study: 14571607

Group type: EXPERIMENTAL
Intervention: Somatostatin (250 micrograms/h for 72 hours) combined with TCM-WM
Number of subjects: 60

Group type: COMPARATOR
Intervention: Baseline treated group (TCM-WM only)
Number of subjects: 60
Study: 11084248

Group type: EXPERIMENTAL
Intervention: Aflurax (pectin-based anti-reflux formulation)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 9184259

Group type: EXPERIMENTAL
Intervention: Simple trapezectomy without interposition material
Number of subjects: 20
Study: 1583939

Group type: EXPERIMENTAL
Intervention: Standard gamble utility
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Categorical rating utility
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Standard gamble utilities
Number of subjects: 73
Study: 3792351

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Minoxidil
Number of subjects: 17
Study: 29861254

Group type: EXPERIMENTAL
Intervention: Infrapatellar bandage
Number of subjects: 40
Study: 27465906

Group type: EXPERIMENTAL
Intervention: Enteric-coated formulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second formulation prototype (single-unit core and enteric-coating film)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release formulation
Number of subjects: 0
Study: 23740231

Group type: EXPERIMENTAL
Intervention: Naproxen (NPX) 1000 mg/d
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 80
Study: 23039926

Group type: EXPERIMENTAL
Intervention: Multi-tiered oral health education programme
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 154
Study: 19855293

Group type: EXPERIMENTAL
Intervention: SITA SWAP tests
Number of subjects: 27
Study: 18502251

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) microskills
Number of subjects: 67
Study: 15835284

Group type: EXPERIMENTAL
Intervention: Modified Constraint-Induced Movement Therapy (m-CIMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 12781934

Group type: EXPERIMENTAL
Intervention: Medication self-management program
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 43
Study: 10475621

Group type: EXPERIMENTAL
Intervention: High-dose therapy and bone marrow transplant with HLA-identical sibling donor
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High-dose therapy and bone marrow transplant with alternative donor (non-HLA-identical sibling)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High-dose therapy and bone marrow transplant with autotransplant
Number of subjects: 9

Group type: COMPARATOR
Intervention: Conventional therapy (interferon and/or chemotherapy)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Preference between donor types
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Alternative donor versus autotransplant
Number of subjects: 9
Study: 8623168

Group type: EXPERIMENTAL
Intervention: Cyclosporine emulsion
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 101
Study: 1911473

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy
Number of subjects: 2000
Study: 6126894

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metipranolol (5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metipranolol (20 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31013204

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (5 mg/kg Dextrose)
Number of subjects: 22
Study: 29244251

Group type: EXPERIMENTAL
Intervention: B vitamin supplementation (folic acid 2.5 mg/day, vitamin B6 50 mg/day, vitamin B12 1 mg/day)
Number of subjects: 4810

Group type: EXPERIMENTAL
Intervention: B vitamin supplementation
Number of subjects: 4810

Group type: COMPARATOR
Intervention: Control group (no B vitamin supplementation)
Number of subjects: 4810
Study: 25833778

Group type: EXPERIMENTAL
Intervention: 160 mg of anthocyanins twice daily
Number of subjects: 58
Study: 25029830

Group type: EXPERIMENTAL
Intervention: Periosteal dissector
Number of subjects: 220

Group type: COMPARATOR
Intervention: Electric scalpel
Number of subjects: 220
Study: 22956832

Group type: EXPERIMENTAL
Intervention: Gamma-band activity (60-80 Hz) in left Brodmann area 9 (BA9)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Alpha frequencies (10-14 Hz) in Brodmann area 6
Number of subjects: 25
Study: 19513797

Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable silicone gastric banding (LASGB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laparoscopic vertical banded gastroplasty (LVBG)
Number of subjects: 100
Study: 17220905

Group type: EXPERIMENTAL
Intervention: Fludarabine (Flu) 40 mg/m(2)/day x 5 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cladribine (Clad) 10 mg/m(2)/day x 5 days plus oral busulfan (1 mg/kg q6 h x 2 days) and total body irradiation 200 cGy
Number of subjects: 32
Study: 15079003

Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy (ERT) with agalsidase beta
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 22
Study: 12172831

Group type: EXPERIMENTAL
Intervention: 3 month combined dietary-behavioural-exercise intervention
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: 6 month continued intervention
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 177
Study: 9522145

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Metoclopramide 10 mg
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1044
Study: 8611993

Group type: EXPERIMENTAL
Intervention: Bipolar scissors (Evershears, Everest Medical)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Monopolar scissors (Endoshears, United States Surgical Corporation)
Number of subjects: 80
Study: 2751738

Group type: EXPERIMENTAL
Intervention: Isosorbide‐5‐mononitrate sustained-release capsules (Olicard 40 retard)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard‐release formulation of isosorbide‐5‐mononitrate
Number of subjects: 12
Study: 155098

Group type: EXPERIMENTAL
Intervention: Timolol, administered twice a day
Number of subjects: 110

Group type: COMPARATOR
Intervention: Pilocarpine, administered four times a day
Number of subjects: 110
Study: 31270082

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) treatment
Number of subjects: 180

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 180
Study: 28130888

Group type: EXPERIMENTAL
Intervention: Warm lidocaine and tetracaine patch
Number of subjects: 339

Group type: COMPARATOR
Intervention: EMLA cream
Number of subjects: 339
Study: 26089305

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 946

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural therapy (ICBT)
Number of subjects: 946

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 946

Group type: EXPERIMENTAL
Intervention: All groups (exercise, ICBT, TAU)
Number of subjects: 946
Study: 23157172

Group type: EXPERIMENTAL
Intervention: Low-salt treatment 6.6 mg/m(3)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: High-salt treatment 10.8 mg/m(3)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo 0.3 mg/m(3)
Number of subjects: 39
Study: 21793716

Group type: EXPERIMENTAL
Intervention: Indacaterol 300 μg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 18615480

Group type: EXPERIMENTAL
Intervention: ERCC1 8092 C > A allele
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: CC haplotype of ERCC1
Number of subjects: 267
Study: 16707635

Group type: EXPERIMENTAL
Intervention: 2-octylcyanoacrylate
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 51
Study: 15112094

Group type: EXPERIMENTAL
Intervention: Imageless computer-assisted implantation technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 80
Study: 11273941

Group type: EXPERIMENTAL
Intervention: IV ketorolac (Group K)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline (Group C)
Number of subjects: 50
Study: 10423632

Group type: EXPERIMENTAL
Intervention: 60 microg PGE (1) administered intravenously (i.v.) in 100 mL saline solution over 2 hours each day for 14 days.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo administered intravenously (i.v.) in 100 mL saline solution over 2 hours each day for 14 days.
Number of subjects: 50
Study: 8287162

Group type: EXPERIMENTAL
Intervention: C-peptide levels after ingestion of Sustacal
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Clinical definitions for type of diabetes
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Discriminant analysis
Number of subjects: 3711

Group type: COMPARATOR
Intervention: Clinically derived definitions
Number of subjects: 3711
Study: 3549323

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg given orally at bedtime for 7 consecutive days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triazolam 0.5 mg given orally at bedtime for 7 consecutive days
Number of subjects: 0
Study: 30043714

Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin plus 10 mg tadalafil daily for 7 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.4 mg tamsulosin plus placebo
Number of subjects: 80
Study: 26437922

Group type: EXPERIMENTAL
Intervention: School-based weight management intervention (24 weeks)
Number of subjects: 61
Study: 25501074

Group type: COMPARATOR
Intervention: Placebo acupuncture using a pragmatic placebo needle (no skin penetration)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Real acupuncture using a real needle (15 mm skin penetration)
Number of subjects: 60
Study: 22651946

Group type: EXPERIMENTAL
Intervention: Guideline-based parenteral hydration therapy
Number of subjects: 161
Study: 20175126

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted ileocolic resection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open ileocolic resection
Number of subjects: 60
Study: 18822977

Group type: EXPERIMENTAL
Intervention: Acupoint-injection group (2 mg Morphine into bilateral Neiguan (PC 6))
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous injection group (5 mg Morphine)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Hypodermic injection group (5 mg Morphine)
Number of subjects: 90
Study: 16884978

Group type: EXPERIMENTAL
Intervention: Morphine (40 mg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Fentanyl (1,000 mug)
Number of subjects: 46
Study: 14695923

Group type: EXPERIMENTAL
Intervention: CoQ10 100 mg t.i.d.
Number of subjects: 550

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 550
Study: 10787771

Group type: EXPERIMENTAL
Intervention: Worksite-plus-family condition
Number of subjects: 1359

Group type: EXPERIMENTAL
Intervention: Worksite-only condition
Number of subjects: 1359

Group type: COMPARATOR
Intervention: Minimal intervention control
Number of subjects: 1359
Study: 8792791

Group type: EXPERIMENTAL
Intervention: Externally coordinated quality assurance intervention
Number of subjects: 16

Group type: COMPARATOR
Intervention: Internal quality assurance
Number of subjects: 16
Study: 1377295

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control
Number of subjects: 96
Study: 6337131

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 44

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 44
Study: 30737332

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control
Number of subjects: 816

Group type: COMPARATOR
Intervention: Standard blood pressure control
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Intensive glycemic control
Number of subjects: 816

Group type: COMPARATOR
Intervention: Standard glycemic control
Number of subjects: 816
Study: 27643913

Group type: EXPERIMENTAL
Intervention: 24 weeks of scripted, classroom-based, book-based intervention targeting code- and meaning-related emergent literacy skills.
Number of subjects: 137

Group type: COMPARATOR
Intervention: Business as usual control group (2 classes).
Number of subjects: 137
Study: 27195435

Group type: EXPERIMENTAL
Intervention: 0.3 mg ramosetron
Number of subjects: 1102

Group type: COMPARATOR
Intervention: 4 mg ondansetron
Number of subjects: 1102
Study: 25048500

Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl
Number of subjects: 200

Group type: COMPARATOR
Intervention: Loxoprofen
Number of subjects: 200

Group type: COMPARATOR
Intervention: Tramadol/acetaminophen
Number of subjects: 200
Study: 22760642

Group type: EXPERIMENTAL
Intervention: Milk fortified with 10 mg Fe/L as ferrous sulfate
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Milk fortified with 10 mg Fe/L and 5 mg Zn/L as Zn sulfate
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Milk fortified with 10 mg Fe/L and 10 mg Zn/L as Zn sulfate
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Milk fortified with 10 mg Fe/L and 20 mg Zn/L as Zn sulfate
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Milk fortified with 10 mg Fe/L and ascorbic acid (70 mg/L)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Milk fortified with 10 mg Fe/L and 5 mg Zn/L as Zn sulfate and ascorbic acid (70 mg/L)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Milk fortified with 10 mg Fe/L and 10 mg Zn/L as Zn sulfate and ascorbic acid (70 mg/L)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Milk fortified with 10 mg Fe/L and 20 mg Zn/L as Zn sulfate and ascorbic acid (70 mg/L)
Number of subjects: 28
Study: 21344836

Group type: EXPERIMENTAL
Intervention: Teeth with ferrule (>2 mm height) - Group A (45 teeth)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Teeth without ferrule (<2 mm height) - Group B (42 teeth)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Overall restorations
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Incisors
Number of subjects: 87
Study: 17661199

Group type: EXPERIMENTAL
Intervention: Spontaneous opioid withdrawal (OW)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No spontaneous opioid withdrawal (absence of OW)
Number of subjects: 6
Study: 15644005

Group type: EXPERIMENTAL
Intervention: Intubating Laryngeal Mask Airway (ILMA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Laryngeal Tube (LT)
Number of subjects: 51
Study: 12133500

Group type: EXPERIMENTAL
Intervention: Bifendate (higher doses: 30-45 mg/d for ages <= 12, 45-67.5 mg/d for ages > 12) for up to 12 months
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Bifendate (higher doses)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 119
Study: 10416048

Group type: EXPERIMENTAL
Intervention: Oleate-rich diet (MUFA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Linoleate-rich diet (PUFA)
Number of subjects: 22
Study: 7575719

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody (MAb) CAMPATH‐1H treatment
Number of subjects: 10
Study: 1710655

Group type: EXPERIMENTAL
Intervention: High-dose cisplatin (40 mg/m2 daily for 5 days)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Standard-dose cisplatin (20 mg/m2 daily for 5 days)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: High-dose cisplatin
Number of subjects: 159

Group type: COMPARATOR
Intervention: Standard-dose cisplatin
Number of subjects: 159
Study: 7233157

Group type: EXPERIMENTAL
Intervention: High sodium water (107 mg Na/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low sodium water (from low sodium community with no sodium added)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low sodium water (from comparison community with sodium added to high sodium level)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High sodium water (from high sodium community)
Number of subjects: 0
Study: 30293198

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (70 µg [2800 IU] daily for 3 months)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 29958037

Group type: EXPERIMENTAL
Intervention: CALM (psychotherapeutic intervention)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 305
Study: 27798013

Group type: EXPERIMENTAL
Intervention: PCV13 (13-valent pneumococcal conjugate vaccine)
Number of subjects: 1040

Group type: COMPARATOR
Intervention: PCV7 (7-valent pneumococcal conjugate vaccine)
Number of subjects: 1040
Study: 25132608

Group type: EXPERIMENTAL
Intervention: Four nights of REM sleep deprivation (RD)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Normal uninterrupted sleep (Control)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Two nights of total sleep deprivation (TD)
Number of subjects: 31
Study: 22156917

Group type: EXPERIMENTAL
Intervention: Chlorhexidine diacetate 10% weight per volume (w/v) dental coating (CHX)
Number of subjects: 983

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 983
Study: 19129748

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (2.5-100 mg daily for 14 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (20-50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0
Study: 17849143

Group type: EXPERIMENTAL
Intervention: HRV-guided training (n = 9)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Training group (TRA) (n = 8)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (n = 9)
Number of subjects: 26
Study: 15512856

Group type: EXPERIMENTAL
Intervention: 400 mg PAS
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 600 mg PAS
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 800 mg PAS
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 11158017

Group type: EXPERIMENTAL
Intervention: Hormonal replacement therapy (estradiol valerate at 2 mg/day for 11 days and cyproterone acetate at 1 mg/day for 10 days; group C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Estradiol alone (patches with E(2) release of 50 microg/24 h; group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (group A)
Number of subjects: 60
Study: 9747678

Group type: EXPERIMENTAL
Intervention: 70% isopropyl alcohol swabs (cleaned group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (not cleaned)
Number of subjects: 66
Study: 7839099

Group type: EXPERIMENTAL
Intervention: Nested primer polymerase chain reaction (PCR) for detection of Mycobacterium paratuberculosis DNA
Number of subjects: 24
Study: 2852540

Group type: EXPERIMENTAL
Intervention: Fibre yoghurt (150 ml containing lactitol, guar gum, and wheat bran) twice daily for 2 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control yoghurt (150 ml without lactitol, guar gum, or wheat bran) twice daily for 2 weeks
Number of subjects: 33
Study: 31359842

Group type: EXPERIMENTAL
Intervention: Motor imagery (MI)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tactile feedback (TF)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Common verbal explanation (MCTE-control group)
Number of subjects: 48
Study: 29980042

Group type: COMPARATOR
Intervention: 0 ppb (filtered air)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: 70 ppb ozone
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: 120 ppb ozone
Number of subjects: 87